Pharmazam

Pharmazam is a private U.S. healthcare technology company focused on pharmacogenomics-guided medication management rather than traditional drug development. The company markets a physician-ordered system that combines genetic testing, medication interaction analysis, and software tools to help identify safer and more effective medication choices for individual patients. Its platform evaluates drug-to-gene, drug-to-drug, drug-to-allergy, drug-to-disease, drug-to-food, and lifestyle-related interactions using a patient’s health profile and genetic information. Pharmazam appears to operate commercially as a personalized medicine and digital health company serving patients and physicians, with testing performed through accredited third-party laboratories. The company does not appear to have a disclosed therapeutic pipeline in the conventional biotech sense.